159 related articles for article (PubMed ID: 25011526)
1. Roles of CXCL5 on migration and invasion of liver cancer cells.
Xu X; Huang P; Yang B; Wang X; Xia J
J Transl Med; 2014 Jul; 12():193. PubMed ID: 25011526
[TBL] [Abstract][Full Text] [Related]
2. CXCL5 Plays a Promoting Role in Osteosarcoma Cell Migration and Invasion in Autocrine- and Paracrine-Dependent Manners.
Dang H; Wu W; Wang B; Cui C; Niu J; Chen J; Chen Z; Liu Y
Oncol Res; 2017 Jan; 25(2):177-186. PubMed ID: 28277189
[TBL] [Abstract][Full Text] [Related]
3. CXCL5 promotes the proliferation and migration of glioma cells in autocrine- and paracrine-dependent manners.
Dai Z; Wu J; Chen F; Cheng Q; Zhang M; Wang Y; Guo Y; Song T
Oncol Rep; 2016 Dec; 36(6):3303-3310. PubMed ID: 27748886
[TBL] [Abstract][Full Text] [Related]
4. CXCL5 regulation of proliferation and migration in human non-small cell lung cancer cells.
Wang L; Shi L; Gu J; Zhan C; Xi J; Ding J; Ge D
J Physiol Biochem; 2018 May; 74(2):313-324. PubMed ID: 29526026
[TBL] [Abstract][Full Text] [Related]
5. [Expression and role of CXC chemokine 5 in liver cancer cells].
Xu XJ; Yang BW; Gong FX; Huang PX; Wu WZ; Xia JL
Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(38):2716-9. PubMed ID: 23290114
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma.
Zhou SL; Dai Z; Zhou ZJ; Wang XY; Yang GH; Wang Z; Huang XW; Fan J; Zhou J
Hepatology; 2012 Dec; 56(6):2242-54. PubMed ID: 22711685
[TBL] [Abstract][Full Text] [Related]
7. CXCL5/CXCR2 axis promotes bladder cancer cell migration and invasion by activating PI3K/AKT-induced upregulation of MMP2/MMP9.
Gao Y; Guan Z; Chen J; Xie H; Yang Z; Fan J; Wang X; Li L
Int J Oncol; 2015 Aug; 47(2):690-700. PubMed ID: 26058729
[TBL] [Abstract][Full Text] [Related]
8. CXCL5 contributes to tumor metastasis and recurrence of intrahepatic cholangiocarcinoma by recruiting infiltrative intratumoral neutrophils.
Zhou SL; Dai Z; Zhou ZJ; Chen Q; Wang Z; Xiao YS; Hu ZQ; Huang XY; Yang GH; Shi YH; Qiu SJ; Fan J; Zhou J
Carcinogenesis; 2014 Mar; 35(3):597-605. PubMed ID: 24293410
[TBL] [Abstract][Full Text] [Related]
9. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.
Kawamura M; Toiyama Y; Tanaka K; Saigusa S; Okugawa Y; Hiro J; Uchida K; Mohri Y; Inoue Y; Kusunoki M
Eur J Cancer; 2012 Sep; 48(14):2244-51. PubMed ID: 22197219
[TBL] [Abstract][Full Text] [Related]
10. CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling.
Zhou SL; Zhou ZJ; Hu ZQ; Li X; Huang XW; Wang Z; Fan J; Dai Z; Zhou J
Cancer Lett; 2015 Mar; 358(2):124-135. PubMed ID: 25462858
[TBL] [Abstract][Full Text] [Related]
11. Activated CXCL5-CXCR2 axis promotes the migration, invasion and EMT of papillary thyroid carcinoma cells via modulation of β-catenin pathway.
Cui D; Zhao Y; Xu J
Biochimie; 2018 May; 148():1-11. PubMed ID: 29471001
[TBL] [Abstract][Full Text] [Related]
12. High C-X-C motif chemokine 5 expression is associated with malignant phenotypes of prostate cancer cells via autocrine and paracrine pathways.
Qi Y; Zhao W; Li M; Shao M; Wang J; Sui H; Yu H; Shao W; Gui S; Li J; Jia X; Jiang D; Li Y; Zhang P; Wang S; Wang W
Int J Oncol; 2018 Jul; 53(1):358-370. PubMed ID: 29749439
[TBL] [Abstract][Full Text] [Related]
13. CXCL5 as an autocrine or paracrine cytokine is associated with proliferation and migration of hepatoblastoma HepG2 cells.
Yang Y; Hou J; Shao M; Zhang W; Qi Y; E S; Wang S; Sui H; Meng D; Wang B; Wang M; Han Y; Cao Y; Huang X; Li Y; Zhang P; Wang W
Oncol Lett; 2017 Dec; 14(6):7977-7985. PubMed ID: 29344240
[TBL] [Abstract][Full Text] [Related]
14. Necroptosis in pancreatic cancer promotes cancer cell migration and invasion by release of CXCL5.
Ando Y; Ohuchida K; Otsubo Y; Kibe S; Takesue S; Abe T; Iwamoto C; Shindo K; Moriyama T; Nakata K; Miyasaka Y; Ohtsuka T; Oda Y; Nakamura M
PLoS One; 2020; 15(1):e0228015. PubMed ID: 31999765
[TBL] [Abstract][Full Text] [Related]
15. The potential of CXCL5 as a target for liver cancer - what do we know so far?
Xia J; Xu X; Huang P; He M; Wang X
Expert Opin Ther Targets; 2015 Feb; 19(2):141-6. PubMed ID: 25495348
[TBL] [Abstract][Full Text] [Related]
16. The CXCL5/CXCR2 axis contributes to the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by activating ERK/GSK-3β/snail signalling.
Qiu WZ; Zhang HB; Xia WX; Ke LR; Yang J; Yu YH; Liang H; Huang XJ; Liu GY; Li WZ; Xiang YQ; Kang TB; Guo X; Lv X
J Exp Clin Cancer Res; 2018 Apr; 37(1):85. PubMed ID: 29665837
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of CXCL5 inhibits squamous carcinogenesis.
Miyazaki H; Patel V; Wang H; Edmunds RK; Gutkind JS; Yeudall WA
Cancer Res; 2006 Apr; 66(8):4279-84. PubMed ID: 16618752
[TBL] [Abstract][Full Text] [Related]
18. A S100A14-CCL2/CXCL5 signaling axis drives breast cancer metastasis.
Li X; Wang M; Gong T; Lei X; Hu T; Tian M; Ding F; Ma F; Chen H; Liu Z
Theranostics; 2020; 10(13):5687-5703. PubMed ID: 32483412
[No Abstract] [Full Text] [Related]
19. CXCL5 knockdown expression inhibits human bladder cancer T24 cells proliferation and migration.
Zheng J; Zhu X; Zhang J
Biochem Biophys Res Commun; 2014 Mar; 446(1):18-24. PubMed ID: 24583128
[TBL] [Abstract][Full Text] [Related]
20. CXCL5/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target.
Zhang W; Wang H; Sun M; Deng X; Wu X; Ma Y; Li M; Shuoa SM; You Q; Miao L
Cancer Commun (Lond); 2020 Mar; 40(2-3):69-80. PubMed ID: 32237072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
